These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 27289365

  • 21. Determining the subjective and physiological effects of BZP on human females.
    Lin JC, Bangs N, Lee H, Kydd RR, Russell BR.
    Psychopharmacology (Berl); 2009 Dec; 207(3):439-46. PubMed ID: 19777213
    [Abstract] [Full Text] [Related]

  • 22. In vitro hepatotoxicity of 'Legal X': the combination of 1-benzylpiperazine (BZP) and 1-(m-trifluoromethylphenyl)piperazine (TFMPP) triggers oxidative stress, mitochondrial impairment and apoptosis.
    Dias da Silva D, Silva MJ, Moreira P, Martins MJ, Valente MJ, Carvalho F, Bastos ML, Carmo H.
    Arch Toxicol; 2017 Mar; 91(3):1413-1430. PubMed ID: 27358233
    [Abstract] [Full Text] [Related]

  • 23. Validation of an LC-MS method for the detection and quantification of BZP and TFMPP and their hydroxylated metabolites in human plasma and its application to the pharmacokinetic study of TFMPP in humans.
    Antia U, Tingle MD, Russell BR.
    J Forensic Sci; 2010 Sep; 55(5):1311-8. PubMed ID: 20533987
    [Abstract] [Full Text] [Related]

  • 24. In vivo interactions between BZP and TFMPP (party pill drugs).
    Antia U, Tingle MD, Russell BR.
    N Z Med J; 2009 Sep 25; 122(1303):29-38. PubMed ID: 19851418
    [Abstract] [Full Text] [Related]

  • 25. Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys.
    Fantegrossi WE, Winger G, Woods JH, Woolverton WL, Coop A.
    Drug Alcohol Depend; 2005 Feb 14; 77(2):161-8. PubMed ID: 15664717
    [Abstract] [Full Text] [Related]

  • 26. Investigation of the first deaths in the United Kingdom involving the detection and quantitation of the piperazines BZP and 3-TFMPP.
    Elliott S, Smith C.
    J Anal Toxicol; 2008 Mar 14; 32(2):172-7. PubMed ID: 18334102
    [Abstract] [Full Text] [Related]

  • 27. "They're legal so they're safe, right?" What did the legal status of BZP-party pills mean to young people in New Zealand?
    Sheridan J, Butler R.
    Int J Drug Policy; 2010 Jan 14; 21(1):77-81. PubMed ID: 19321329
    [Abstract] [Full Text] [Related]

  • 28. [1-benzylpiperazine (BZP) and 1-(3-trifluorométhylphényl)pipérazine (TFMPP): emergence of two agents which lead to misuse].
    Lecompte Y, Roussel O, Perrin M.
    Ann Pharm Fr; 2008 Mar 14; 66(2):85-91. PubMed ID: 18570904
    [Abstract] [Full Text] [Related]

  • 29. 'Party pill' drugs--BZP and TFMPP.
    Antia U, Tingle MD, Russell BR.
    N Z Med J; 2009 Dec 11; 122(1307):55-68. PubMed ID: 20148045
    [Abstract] [Full Text] [Related]

  • 30. Partying on? Life after BZP-based party pills.
    Green JA.
    N Z Med J; 2008 Oct 03; 121(1283):35-42. PubMed ID: 18841183
    [Abstract] [Full Text] [Related]

  • 31. The impact of New Zealand's 2008 prohibition of piperazine-based party pills on young people's substance use: results of a longitudinal, web-based study.
    Sheridan J, Dong CY, Butler R, Barnes J.
    Int J Drug Policy; 2013 Sep 03; 24(5):412-22. PubMed ID: 23499366
    [Abstract] [Full Text] [Related]

  • 32. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
    Tsutsumi H, Katagi M, Miki A, Shima N, Kamata T, Nishikawa M, Nakajima K, Tsuchihashi H.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May 25; 819(2):315-22. PubMed ID: 15833296
    [Abstract] [Full Text] [Related]

  • 33. Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP).
    Wood DM, Button J, Lidder S, Ramsey J, Holt DW, Dargan PI.
    J Med Toxicol; 2008 Dec 25; 4(4):254-7. PubMed ID: 19031377
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Impure but not inactive: Behavioral pharmacology of dibenzylpiperazine, a common by-product of benzylpiperazine synthesis.
    Dolan SB, Shetty RA, Forster MJ, Gatch MB.
    J Psychopharmacol; 2018 Jul 25; 32(7):802-810. PubMed ID: 29909719
    [Abstract] [Full Text] [Related]

  • 36. Benzylpiperazine: a drug of abuse?
    Johnstone AC, Lea RA, Brennan KA, Schenk S, Kennedy MA, Fitzmaurice PS.
    J Psychopharmacol; 2007 Nov 25; 21(8):888-94. PubMed ID: 17606471
    [Abstract] [Full Text] [Related]

  • 37. Update on 1-benzylpiperazine (BZP) party pills.
    Monteiro MS, Bastos Mde L, Guedes de Pinho P, Carvalho M.
    Arch Toxicol; 2013 Jun 25; 87(6):929-47. PubMed ID: 23685794
    [Abstract] [Full Text] [Related]

  • 38. Information processing and interhemispheric transfer in left- and right-handed adults.
    Savage CR, Thomas DG.
    Int J Neurosci; 1993 Jun 25; 71(1-4):201-19. PubMed ID: 8407146
    [Abstract] [Full Text] [Related]

  • 39. Isotopic profiling of seized benzylpiperazine and trifluoromethylphenylpiperazine tablets using δ13C and δ15N stable isotopes.
    Beckett NM, Cresswell SL, Grice DI, Carter JF.
    Sci Justice; 2015 Jan 25; 55(1):51-6. PubMed ID: 25577007
    [Abstract] [Full Text] [Related]

  • 40. Dexamphetamine reduces auditory P3 delta power and phase-locking while increasing gamma power.
    Albrecht MA, Price G, Lee J, Iyyalol R, Martin-Iverson MT.
    Eur Neuropsychopharmacol; 2012 Oct 25; 22(10):734-46. PubMed ID: 22440975
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.